Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021067834 - CANNABINOIDS AND USES THEREOF

Publication Number WO/2021/067834
Publication Date 08.04.2021
International Application No. PCT/US2020/054103
International Filing Date 02.10.2020
IPC
A61K 31/05 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61K 31/235 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
235having an aromatic ring attached to a carboxyl group
C07C 37/50 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
37Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
50by reactions decreasing the number of carbon atoms
Applicants
  • CORBUS PHARMACEUTICALS, INC. [US]/[US]
Inventors
  • DENG, Hongfeng
  • EVRON, Tama
  • JIN, Zhuang
  • LEIGH, Clifton, David
Agents
  • ELLISON, Jeffrey, J.
Priority Data
62/910,11103.10.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) CANNABINOIDS AND USES THEREOF
(FR) CANNABINOÏDES ET UTILISATIONS ASSOCIÉES
Abstract
(EN)
The invention relates to cannabinoid compounds, pharmaceutical compositions including one or more cannabinoid compounds, and the use of pharmaceutical compositions including one or more cannabinoid compounds for the treatment of a disease or condition (e.g., a fibrotic disease or an inflammatory disease) in a subject in need thereof.
(FR)
L'invention concerne des composés cannabinoïdes, des compositions pharmaceutiques comprenant un ou plusieurs composés cannabinoïdes et l'utilisation de compositions pharmaceutiques comprenant un ou plusieurs composés cannabinoïdes pour le traitement d'une maladie ou d'une affection (par exemple, une maladie fibrotique ou une maladie inflammatoire) chez un sujet qui en a besoin.
Latest bibliographic data on file with the International Bureau